IECP Devices from TMC Europa Ltd.
TMC Europa Ltd. offers four models in its IECP devices range. The first two models "TMC-Brisk" and "SL-100" are based on the legacy Volume technology. The SL-200 and the SL-200e are based on the newer Velocity technology. Devices in Velocity technology are more rugged and efficient. Click the image below as per your choice for more information.
You could find information relative to ECP therapy or ECP equipment. You can also go through various FAQs and find answers to questions you may have.
The most widely used ECP device is the SL-200 click the above link to navigate to the relevant page. You will get most of the information on the device.
To go to a general price quote section where you will choose the equipment you want the price quote for please click the link above to take you there.
Dr Sandeep Patel National Human Therapeutics, Gujrat in India. Our experience with the IECP system: We had been using your IECP system for the last three and half years. We mainly bought this system because of two reasons: commercially effective price and faster service & support as company has service center in India and we do not have to rely on parts coming from other countries.
As of now we have done around 218 patients, with indications of single vessel disease, multi-vessel disease, left ventricular dysfunction, heart failure, refractory angina and myocardial infarction. We are happy with the results and thank TMC for their prompt services.
Dr. Jyotsna Patil. Pune preventive Cardiology, Maharashtra. We have been using the Sl-200 IECP system for more than 8 years and we are very happy with the results and also the support from TMC, we are placing an order for one more IECP system SL-200 for our other center…
Dr. K B Shah ( Shah Hospital, Maharashtra) Increased external counterpulsation (IECP) is a non-invasive treatment for patients with coronary artery disease and heart failure. The SL-200 IECP system was used for the treatment of 246 patients suffering from coronary artery disease. Most of these patients had already undergone PTCA. The patients were aged between 42 and 78 years, and 164 patients had multi-vessel disease. All patients were taken up for 35 hours protocol for IECP therapy. After completion of the treatment protocol, we observed remarkable improvement in 228 patients. It gives us immense satisfaction and happiness that we could treat these patients suffering from coronary artery disease, congestive heart failure, stable or unstable angina and acute myocardial infarction, without any surgery. We highly recommend increased external counterpulsation therapy.
Dr. Harish Gupta ( Life Line Hospital, Rajasthan.) We mainly purchased the IECP system only for no-option patients, who are not fit for interventions like PTCA or CABG. The results of the IECP therapy are very encouraging, we feel very happy when we see our patients leading a healthy & happy life after the IECP therapy..